Melanoma Breakthroughs and the Promise of Curative Therapy | Scott Schliebner
What happens when a treatment has the potential to cure disease rather than manage it for years?
Scott Schliebner returns to BioTalk Unzipped for a deeper discussion of rare disease clinical trials, gene therapy, cell therapy, cancer treatment, and one of the most difficult questions in modern medicine: how should potentially curative therapies be valued and made accessible?
Scott first expands on the operational complexity of rare disease studies, including patient recruitment, multidisciplinary care, and the importance of collaboration among stakeholders.
The conversation then examines how…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.